Adverse events higher with concomitant SUI surgery
February 1st 2008Patients undergoing surgical treatment for stress incontinence with concomitant surgical repair, including anterior or posterior/apical repair and other non-prolapse procedures, appear to be at higher risk for wound-related or genitourinary complications.
Prolapse repair plus Burch improves 2-year outcomes
February 1st 2008Offering a concomitant Burch colposuspension to stress-continent women undergoing sacrocolpopexy not only appears to protect patients from later stress urinary incontinence, but it also may improve symptoms of urge incontinence above and beyond the effects of the prolapse repair alone.
Repeat resection emphasized in new bladder cancer guideline
February 1st 2008Among the many recommendations within the new AUA guideline for the management of nonmuscle-invasive bladder cancer, arguably one of the most important is the idea of repeating resection for patients with high-grade Ta or T1 disease within a few weeks of the initial resection before making a treatment recommendation.
Repeat resection emphasized in new bladder cancer guideline
February 1st 2008Among the many recommendations within the new AUA guideline for the management of nonmuscle-invasive bladder cancer, arguably one of the most important is the idea of repeating resection for patients with high-grade Ta or T1 disease within a few weeks of the initial resection before making a treatment recommendation.
Urge symptoms, advanced prolapse raise treatment failure
February 1st 2008Women with greater baseline urge incontinence symptoms, those with more advanced pelvic organ prolapse, and postmenopausal women not on hormone replacement therapy (HRT) are all at greater risk for treatment failure when undergoing Burch and sling procedures for stress urinary incontinence.
Novel laparoscopic partial nephrectomy technique avoids vascular clamping effects
February 1st 2008Use of hemostatic hydrodissection and bipolar vessel coagulation appears to be a viable method for avoiding vascular clamping and subsequent renal ischemia while performing laparoscopic or robotic partial nephrectomy.
Botulinum effective in refractory urge incontinence
February 1st 2008Botulinum toxin A (Botox) is highly effective as a treatment for refractory urge incontinence symptoms in women with urodynamic evidence of detrusor overactivity incontinence, but patients require assessment for transient urinary retention.
At 1 year, TOT is equal/superior to TVT in stress urinary incontinence
February 1st 2008A recent multicenter study provides some justification for the increasing popularity of transobturator slings in the treatment of stress urinary incontinence in patients with and without concurrent pelvic organ prolapse.
Dr. Kuettel selected for National Quality Forum leadership team
January 31st 2008Michael Kuettel, MD, PhD, chairman of the department of radiation medicine at Roswell Park Cancer Institute, has been selected to serve on the steering committee for the National Consensus Standards for Clinical Level Cancer Care of the National Quality Forum.
FDA approves new ED drug dose for once-daily use
January 31st 2008The FDA has approved a new lower-dose regimen of tadalafil (Cialis), an oral erectile dysfunction medication for once-daily use. The 2.5-mg formulation is intended for use by men with ED who anticipate sexual activity at least twice weekly. For other men, the previously approved 5-mg dosing regimen is indicated.
Topical gel promising for overactive bladder patients
January 31st 2008An investigational topical treatment for overactive bladder produced a statistically significant reduction in incontinence episodes and a reduction in frequency, while increasing void volume compared with placebo in a phase III study of oxybutynin topical gel in patients with overactive bladder.
Pros, cons of prostate cancer prevention Rx should be considered
January 31st 2008Findings by University of Texas Southwestern Medical Center researchers encourage men to weigh the potential benefits against the side effects of the drug finasteride (Proscar) before taking it to prevent prostate cancer.
Two-drug therapy improves BPH symptoms
January 31st 2008Men with BPH who take a combination of dutasteride (Avodart) and tamsulosin (Flomax) appear to experience significantly greater improvement in urinary symptoms than do men taking either medication alone, according to findings from the CombAT (Combination of Avodart and Tamsulosin) study.
Combination therapy improves survival in some PCa patients
January 31st 2008Men with localized prostate cancer who are treated with androgen suppression therapy and radiation therapy have longer survival, but those with moderate to high levels of concomitant illness do not experience this effect, according to a study in last week’s JAMA (2008; 299:289-95).